BIG
FBLG icon

Brooklyn Investment Group’s FibroBiologics FBLG Stock Holding History

Brooklyn Investment Group’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-575
Closed -$2.88K – 2036
2025
Q4 		$2.88K Hold
575
– – ﹤0.01% 1498
2025
Q3 		$7.11K Hold
575
– – ﹤0.01% 660
2025
Q2 		$7.16K Hold
575
– – ﹤0.01% 2337
2025
Q1 		$10.3K Hold
575
– – ﹤0.01% 1496
2024
Q4 		$23K Buy
+575
New +$30.9K 0.01% 722

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Brooklyn Investment Group's FBLG Position: Q1 2026 in Review

Brooklyn Investment Group sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 575 shares — an estimated $2.88K sold.

Brooklyn Investment Group first reported a position in FBLG in Q4 2024 and held it in 5 quarters. The position peaked at $23K in Q4 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Brooklyn Investment Group reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 575 FibroBiologics shares in Q1 2026, an estimated $2.88K.
  • Brooklyn Investment Group first reported a position in FibroBiologics in Q4 2024 and held it in 5 quarters.
  • Brooklyn Investment Group's FibroBiologics position peaked at $23K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.